Cancer Screening & PreventionMay 22, 2026·4 min read
By the CIRRUS Editorial Team — how we write and source this
Barrett's esophagus: the precursor condition behind rising interest in esophageal cancer screening
Chronic acid reflux can gradually change the cells lining the esophagus into a precancerous state. Most people who have it don't know, because reflux itself rarely feels alarming.
Barrett's esophagus is a condition where chronic exposure to stomach acid — typically from long-standing gastroesophageal reflux disease — causes the normal cells lining the lower esophagus to be gradually replaced by a different cell type more resistant to acid damage, a change that's the body's adaptive response to chronic irritation but that also carries a meaningfully elevated risk of progressing to esophageal adenocarcinoma over time, one of the faster-rising cancer types in incidence over recent decades in Western countries.
The diagnostic and risk challenge is that Barrett's esophagus itself produces no symptoms distinct from ordinary reflux — someone can have significant Barrett's changes and experience the same heartburn they've had for years without any new or different warning sign, which is why the condition is generally diagnosed incidentally during an endoscopy performed for longstanding reflux symptoms rather than through any screening test triggered by a specific new symptom.
Current guidelines generally recommend considering endoscopic screening for Barrett's esophagus in people with chronic, long-standing GERD symptoms combined with additional risk factors — male sex, age over 50, obesity, smoking history, or a family history of Barrett's or esophageal cancer — rather than for everyone with occasional reflux, since the absolute risk in low-risk reflux patients doesn't currently justify universal endoscopic screening.
Once diagnosed, Barrett's esophagus is managed with periodic surveillance endoscopy at intervals determined by the degree of cellular change found, plus more aggressive acid-suppression treatment, and in higher-risk cases, endoscopic treatments that can remove or ablate the abnormal tissue before it progresses. For anyone with chronic reflux lasting several years, particularly with other risk factors present, raising Barrett's esophagus screening directly with a gastroenterologist is a reasonable step rather than continuing to manage symptoms with over-the-counter medication indefinitely without ever having had an endoscopic evaluation.
This article is general health information, not medical advice, and doesn’t replace evaluation by your own physician. Talk to a doctor about anything specific to your own diagnosis or treatment.